| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-06 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0002 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.0005 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0007 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.002 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |